Evidence of physical ability to perform the requested privilege. Data from professional practice review by an organization(s) that currently privileges the applicant (if available). Peer and/or faculty recommendation. When renewing privileges, review of the practitionerâs performance within the hospital.
Janssen, however, also marketed Risperdal as a treatment for older people with agitation from dementia, which is not an FDA-approved use of the medication. In fact, it can be dangerous for older adults with dementia to take antipsychotics, including Risperdal, and Janssen had to pay a fine for misbranding the drug.
Rating Newest Oldest. Best Answer: Like Zyprexa and the other atypical antipsychotics, Risperdal was developed primarily to treat schizophrenia and psychosis but is approved to treat acute bipolar mania and mixed episodes (mania and depression).ating Newest Oldest. Best Answer: Like Zyprexa and the other atypical antipsychotics, Risperdal was developed primarily to treat schizophrenia and psychosis but is approved to treat acute bipolar mania and mixed episodes (mania and depression).